can glp 1 cause irregular periods How GLP-1 Impacts Women: A Look at Side Effects Wegovy vs Mounjaro: How GLP-1

Cells 36 , 385392 (2013)

For weight management, treatment typically requires at least 612 months, with NICE recommending discontinuation if less than 5% weight loss is achieved after 6 months (Wegovy) or 12 weeks (Saxenda) at maintenance doses

Finally, the expanded indication landscape suggests that the GLP-1 platform will increasingly compete not just within obesity, but across MASH, cardiovascular protection, and potentially other metabolic conditions

These combined effects result in improved postprandial and fasting glucose levels, along with substantial weight loss that varies by indication and dosetypically 5-13% in type 2 diabetes trials and up to 15-20% in obesity trials at the highest doses (15 mg)